{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:16:17Z","timestamp":1772180177957,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Infectious Diseases"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1016\/s1473-3099(02)00347-x","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T13:17:57Z","timestamp":1032268677000},"page":"494-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":535,"title":["Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda"],"prefix":"10.1016","volume":"2","author":[{"given":"Philippe J","family":"Guerin","sequence":"first","affiliation":[]},{"given":"Piero","family":"Olliaro","sequence":"additional","affiliation":[]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[]},{"given":"Marleen","family":"Boelaert","sequence":"additional","affiliation":[]},{"given":"Simon L","family":"Croft","sequence":"additional","affiliation":[]},{"given":"Philippe","family":"Desjeux","sequence":"additional","affiliation":[]},{"given":"Monique K","family":"Wasunna","sequence":"additional","affiliation":[]},{"given":"Anthony DM","family":"Bryceson","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1473-3099(02)00347-X_bib1","first-page":"267","article-title":"Human leishmaniases: epidemiology and public health aspects","volume":"45","author":"Desjeux","year":"1992","journal-title":"World Health Stat Q"},{"key":"10.1016\/S1473-3099(02)00347-X_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0738-081X(96)00057-0","article-title":"Leishmaniasis. Public health aspects and control","volume":"14","author":"Desjeux","year":"1996","journal-title":"Clin Dermatol"},{"key":"10.1016\/S1473-3099(02)00347-X_bib3","series-title":"The world health report","year":"2001"},{"key":"10.1016\/S1473-3099(02)00347-X_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0035-9203(00)90255-4","article-title":"Socio-economics of visceral leishmaniasis in Bihar (India)","volume":"94","author":"Thakur","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3201\/eid0202.960213","article-title":"The re-emergence of visceral leishmaniasis in Brazil","volume":"2","author":"Arias","year":"1996","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/S1473-3099(02)00347-X_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/ije\/25.4.862","article-title":"The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994","volume":"25","author":"Seaman","year":"1996","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S1473-3099(02)00347-X_bib7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(02)00347-X_bib8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0035-9203(82)90095-5","article-title":"Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya","volume":"76","author":"Ho","year":"1982","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib9","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/infdis\/156.6.1030","article-title":"Malnutrition as a risk factor for severe visceral leishmaniasis","volume":"156","author":"Cerf","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(02)00347-X_bib10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.10.2.298","article-title":"Leishmania and human immunodeficiency virus coinfection: the first 10 years","volume":"10","author":"Alvar","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/S1473-3099(02)00347-X_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S1473-3099(02)00347-X_bib12","series-title":"Leishmania and HIV in gridlock. WHO and UN programme on HIV\/AIDS; WHO\/CTD\/LEISH\/98.9","author":"Desjeux","year":"1998"},{"key":"10.1016\/S1473-3099(02)00347-X_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1198-743x.2001.00262.x","article-title":"HIV-associated visceral leishmaniasis","volume":"7","author":"Pintado","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/S1473-3099(02)00347-X_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0001-706X(94)90106-6","article-title":"Endemic disease and development: the leishmaniases","volume":"56","author":"Wijeyaratne","year":"1994","journal-title":"Acta Trop"},{"key":"10.1016\/S1473-3099(02)00347-X_bib15","first-page":"495","article-title":"The global burden of disease in 1990: summary results, sensitivity analysis and future directions","volume":"72","author":"Murray","year":"1994","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S1473-3099(02)00347-X_bib16","first-page":"122","article-title":"Visceral leishmaniasis control in India through primary health care system: a successful experiment of district level planning","volume":"28","author":"Saxena","year":"1996","journal-title":"J Commun Dis"},{"key":"10.1016\/S1473-3099(02)00347-X_bib17","first-page":"62","article-title":"Epidemiology of visceral leishmaniasis in India","volume":"12","author":"Bora","year":"1999","journal-title":"Natl Med J India"},{"key":"10.1016\/S1473-3099(02)00347-X_bib18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00034983.1992.11812717","article-title":"Decreased sensitivity to meglumine antimoniate (Glucantime) of leishmania infantum isolated from dogs after several courses of drug treatment","volume":"86","author":"Gramiccia","year":"1992","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/S1473-3099(02)00347-X_bib19","series-title":"A cutaneous leishmaniasis control trial using pyrethroid impregnated bednets in villages near Aleppo, Syria","author":"Tayeh","year":"1997"},{"key":"10.1016\/S1473-3099(02)00347-X_bib20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1365-2915.1999.00191.x","article-title":"Protective efficacy of lambdacyhalothrin-impregnated bednets against Phlebotomus orientalis, the vector of visceral leishmaniasis in Sudan","volume":"13","author":"Elnaiem","year":"1999","journal-title":"Med Vet Entomol"},{"key":"10.1016\/S1473-3099(02)00347-X_bib21","first-page":"177","article-title":"Laboratory evaluation of lambda-cyhalothrin a microencapsulated formulation on mosquito nets for control of vector mosquitos","volume":"30","author":"Vythilingam","year":"1999","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/S1473-3099(02)00347-X_bib22","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","article-title":"Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan","volume":"356","author":"Khalil","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(02)00347-X_bib23","series-title":"Harrison's principles of internal medicine","first-page":"1189","article-title":"Leishmaniasis","author":"Herwaldt","year":"1999"},{"key":"10.1016\/S1473-3099(02)00347-X_bib24","first-page":"667","article-title":"Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis","volume":"77","author":"Boelaert","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S1473-3099(02)00347-X_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-3156.1999.00348.x","article-title":"Multi-centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis","volume":"4","author":"Boelaert","year":"1999","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S1473-3099(02)00347-X_bib26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(97)04350-X","article-title":"Rapid accurate field diagnosis of Indian visceral leishmaniasis","volume":"351","author":"Sundar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(02)00347-X_bib27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/JCM.39.3.849-854.2001","article-title":"Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala- azar dermal leishmaniasis","volume":"39","author":"Salotra","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S1473-3099(02)00347-X_bib28","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1542\/peds.109.2.e27","article-title":"Polymerase chain reaction in the diagnosis and prognosis of Mediterranean visceral leishmaniasis in immunocompetent children","volume":"109","author":"Cascio","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/S1473-3099(02)00347-X_bib29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.39.1.357-361.2001","article-title":"Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1","volume":"39","author":"Pizzuto","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S1473-3099(02)00347-X_bib30","first-page":"651","article-title":"Diagnostic lag period in kala-azar: test for early diagnosis needed","volume":"39","author":"Sundar","year":"1991","journal-title":"J Assoc Phys India"},{"key":"10.1016\/S1473-3099(02)00347-X_bib31","series-title":"Advances in the therapeutics of antimony","author":"Schmidt","year":"1938"},{"key":"10.1016\/S1473-3099(02)00347-X_bib32","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S1473-3099(02)00347-X_bib33","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","article-title":"Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)","volume":"34","author":"Chulay","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4269\/ajtmh.1998.59.139","article-title":"A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate","volume":"59","author":"Sundar","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib35","first-page":"388","article-title":"Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya","volume":"79","author":"Moore","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S1473-3099(02)00347-X_bib36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0035-9203(01)90110-5","article-title":"Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome","volume":"95","author":"Ritmeijer","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-3156.2000.00555.x","article-title":"A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan","volume":"5","author":"Veeken","year":"2000","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S1473-3099(02)00347-X_bib38","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","article-title":"Clinical and experimental advances in treatment of visceral leishmaniasis","volume":"45","author":"Murray","year":"2001","journal-title":"Antimicrob Ag Chemother"},{"key":"10.1016\/S1473-3099(02)00347-X_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s004300100086","article-title":"Current issues in the treatment of visceral leishmaniasis","volume":"190","author":"Bryceson","year":"2001","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"10.1016\/S1473-3099(02)00347-X_bib40","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S1473-3099(02)00347-X_bib41","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani","volume":"180","author":"Lira","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/S1473-3099(02)00347-X_bib42","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2165\/00003495-199856060-00005","article-title":"Practical guide for the treatment of leishmaniasis","volume":"56","author":"Davidson","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/S1473-3099(02)00347-X_bib43","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0035-9203(85)90197-X","article-title":"Visceral leishmaniasis unresponsive to antimonial drugs: I, clinical and immunological studies","volume":"79","author":"Bryceson","year":"1985","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib44","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0035-9203(00)90112-3","article-title":"Investigation of the spread of human visceral leishmaniasis in central Tunisia","volume":"94","author":"Ben Salah","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib45","first-page":"259","article-title":"Comparison of regimens of amphotericin B deoxycholate in kala-azar","volume":"103","author":"Thakur","year":"1996","journal-title":"Indian J Med Res"},{"key":"10.1016\/S1473-3099(02)00347-X_bib46","first-page":"25","article-title":"Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries","volume":"76","author":"Berman","year":"1998","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S1473-3099(02)00347-X_bib47","first-page":"75","article-title":"Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial","volume":"87","author":"Davidson","year":"1994","journal-title":"QJM"},{"key":"10.1016\/S1473-3099(02)00347-X_bib48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/bmj.323.7310.419","article-title":"Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial","volume":"323","author":"Sundar","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/S1473-3099(02)00347-X_bib49","first-page":"186","article-title":"Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis","volume":"47","author":"Sundar","year":"1999","journal-title":"J Assoc Phys India"},{"issue":"suppl 1","key":"10.1016\/S1473-3099(02)00347-X_bib50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000048471","article-title":"Treatment of visceral leishmaniasis with amphotericin B colloidal dispersion","volume":"45","author":"Berman","year":"1999","journal-title":"Chemotherapy"},{"key":"10.1016\/S1473-3099(02)00347-X_bib51","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00002030-199906180-00009","article-title":"Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B","volume":"13","author":"Laguna","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/S1473-3099(02)00347-X_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0163-4453(96)91343-2","article-title":"Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome)","volume":"32","author":"Russo","year":"1996","journal-title":"J Infect"},{"key":"10.1016\/S1473-3099(02)00347-X_bib53","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/318708","article-title":"Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients","volume":"32","author":"De La Rosa","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S1473-3099(02)00347-X_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1517\/14728214.7.1.61","article-title":"Developments in the treatment of leishmaniasis and trypanosomiasis","volume":"7","author":"Olliaro","year":"2002","journal-title":"Expert Opin Emerging Drugs"},{"key":"10.1016\/S1473-3099(02)00347-X_bib55","series-title":"The crisis of neglected diseases: developing treatments and ensuring access","first-page":"33","article-title":"A harvest not yet reaped: genomics to new drugs in leishmania and trypanosomes","author":"Wirth","year":"2002"},{"key":"10.1016\/S1473-3099(02)00347-X_bib56","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","article-title":"Drug development for neglected diseases: a deficient market and a public-health policy failure","volume":"359","author":"Trouiller","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(02)00347-X_bib57","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(98)04367-0","article-title":"Trial of oral miltefosine for visceral leishmaniasis","volume":"352","author":"Sundar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S1473-3099(02)00347-X_bib58","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00034983.1999.11813462","article-title":"Oral treatment of visceral leishmaniasis with miltefosine","volume":"93","author":"Sundar","year":"1999","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/S1473-3099(02)00347-X_bib59","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S1473-3099(02)00347-X_bib60","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-3156.2001.00795.x","article-title":"A policy for leishmaniasis with respect to the prevention and control of drug resistance","volume":"6","author":"Bryceson","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S1473-3099(02)00347-X_bib61","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0035-9203(00)90131-7","article-title":"Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine): an open-label randomized phase-II clinical study","volume":"94","author":"Thakur","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib62","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.316.7139.1200","article-title":"Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India","volume":"316","author":"Jha","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/S1473-3099(02)00347-X_bib63","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-124-7-199604010-00007","article-title":"Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources","volume":"124","author":"Seaman","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/S1473-3099(02)00347-X_bib64","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0035-9203(92)90151-2","article-title":"Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom","volume":"86","author":"Scott","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib65","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0035-9203(92)90150-B","article-title":"Treatment of visceral leishmaniasis (kala-azar) with aminosidine (paromomycin)-antimonial combinations, a pilot study in Bihar, India","volume":"86","author":"Thakur","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib66","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0035-9203(95)90503-0","article-title":"Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial","volume":"89","author":"Thakur","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib67","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0035-9203(00)90130-5","article-title":"A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis","volume":"94","author":"Thakur","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib68","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/clinids\/19.6.1034","article-title":"Phase 2 efficacy trial of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis","volume":"19","author":"Sherwood","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S1473-3099(02)00347-X_bib69","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4269\/ajtmh.2001.65.685","article-title":"Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi","volume":"65","author":"Dietze","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib70","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1365-3156.1999.00487.x","article-title":"Diagnostic PCR with Leishmania donovani specificity","volume":"4","author":"Boelaert","year":"1999","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S1473-3099(02)00347-X_bib71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4269\/ajtmh.1999.60.129","article-title":"Operational validation of the direct agglutination test for diagnosis of visceral leishmaniasis","volume":"60","author":"Boelaert","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-3156.1999.00348.x","article-title":"Multi-centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis","volume":"4","author":"Boelaert","year":"1999","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S1473-3099(02)00347-X_bib73","first-page":"606","article-title":"Direct agglutination test for early diagnosis of Indian visceral leishmaniasis","volume":"44","author":"Jha","year":"1996","journal-title":"J Assoc Phys India"},{"key":"10.1016\/S1473-3099(02)00347-X_bib74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0035-9203(99)90021-4","article-title":"Evaluation of the direct agglutination test (DAT) using freeze-dried antigen for the detection of anti-Leishmania antibodies in stored sera from various patient groups in Ethiopia","volume":"93","author":"Oskam","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S1473-3099(02)00347-X_bib75","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1365-3156.2001.00680.x","article-title":"Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan","volume":"6","author":"Zijlstra","year":"2001","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S1473-3099(02)00347-X_bib76","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4269\/ajtmh.1995.52.427","article-title":"Short report: detection of 72-75-kD and 123-kD fractions of Leishmania antigen in urine of patients with visceral leishmaniasis","volume":"52","author":"de","year":"1995","journal-title":"Am J Trop Med Hyg"}],"container-title":["The Lancet Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147330990200347X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147330990200347X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:57:25Z","timestamp":1761469045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147330990200347X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S147330990200347X"],"URL":"https:\/\/doi.org\/10.1016\/s1473-3099(02)00347-x","relation":{},"ISSN":["1473-3099"],"issn-type":[{"value":"1473-3099","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","name":"articletitle","label":"Article Title"},{"value":"The Lancet Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1473-3099(02)00347-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}